Chugai Pharmaceutical filed a New Drug Application for the use of emicizumab as a…
Articles by Joana Fernandes, PhD
Results from two Phase 3 trials support the use of emicizumab for the preventive treatment of hemophilia A in children,…
Spark Therapeutics will present novel results regarding the ongoing Phase 1/2 clinical trial (NCT02484092) investigating SPK-9001 in hemophilia…
Decades ago most hemophilia patients died young. Advances in treatment have led to them living about as long as the…
Cellphones are a good way for hemophiliacs receiving care at home to relay information that doctors need to stay on…
Novo Nordisk expects a decision this month by the U.S. Food and Drug Administration (FDA) on its product N9-GP  (nonacog…
More than 12,300 hemophilia cases in developing countries were treated with therapy donations from Bioverativ and its partner Sobi in 2016, Bioverativ…
An infant was diagnosed with severe hemophilia A after developing splenic injury (injury to the spleen), a rare condition among…
The high incidence of hypertension among hemophilia patients may not be associated with common cardiovascular risk factors, such as obesity,…
Researchers have developed a biodegradable capsule to deliver a protein missing in patients with hemophilia B, according to a new…